
Commentary
Trump, Trials Target Drug Company Shareholders in Opioid Cases
The opioid addiction issue is headed for the next stop on what is now a well-worn path: from public health crisis, to subject for award-winning and heart-tugging journalism, to payday for trial lawyers. The lawyers are poised to do to prescription drug companies, pharmacy chains, and drug distributors what they